Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease

키워드

참고문헌 (38)

1. McCullough AJ, "The epidemiology and risk factors of NASH, In Fatty Liver Disease: NASH and Related Disorders", pp.23~37 (2005), Blackwell
2. Farrell GC, "Nonalcoholic fatty liver disease: From steatosis to cirrhosis", Hepatology, 43(1), pp.99~112 (2006)
3. Fan JG, "Fatty liver and the metabolic syndrome among Shanghai adults", J Gastroenterol Hepatol, 20, pp.1825~1832 (2005)
4. 박승하, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, pp.138~143, BLACKWELL PUBLISHING
5. Hamaguchi M, "The metabolic syndrome as a predictor of nonalcoholic fatty liver disease", Ann Intern Med, 143, pp.722~728 (2005)
6. Bugianesi E, "Insulin resistance: a metabolic pathway to chronic liver disease", Hepatology, 42, pp.987~1000 (2005)
7. 박승하, "Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 19, pp.694~698, BLACKWELL PUBLISHING
8. Kerner A, "Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome", Arterioscler Thromb Vasc Biol, 25, pp.193~197 (2005)
9. Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
10. Dixon JB, "Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement", Obes Surg, 16, pp.1278~1286 (2006)
11. Vozarova B, "High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes", Diabetes, 51, pp.1889~1895 (2002)
12. Lee DH, "Association between serum gamma-glutamyltransferase and C-reactive protein", Atherosclerosis, 178, pp.327~330 (2005)
13. Whitfield JB, "Gamma glutamyl transferase", Crit Rev Clin Lab Sci, 38, pp.263~355 (2001)
14. Lee DH, "Is serum gamma glutamyltransferase a marker of oxidative stress", Free Radic Res, 38, pp.535~539 (2004)
15. Marchesini G, "NASH: from liver diseases to metabolic disorders and back to clinical hepatology", Hepatology, 35, pp.497~499 (2002)
16. Saito T, "Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population", Metabolism, 58, pp.1067~1075 (2009)
17. Oh SY, "The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease", Metabolism, 55, pp.1604~1609 (2006)
18. Schindhelm RK, "Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study", Atherosclerosis, 191, pp.391~396 (2007)
19. Goessling W, "Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease", Gastroenterology, 135, pp.1935~1944 (2008)
20. Chang Y, "Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease", Clin Chem, 53, pp.686~692 (2007)
21. Kim HC, "Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study", BMJ, 328, pp.983~ (2004)
22. Penn R, "Is serum gamma-glutamyltransferase a misleading test", Br Med J (Clin Res Ed), 286, pp.531~535 (1983)
23. Goldberg DM, "Structural, functional, and clinical aspects of gamma-glutamyltransferase", CRC Crit Rev Clin Lab Sci, 12, pp.1~58 (1980)
24. Kim CH, "Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver", Diabetes Metab Res Rev, 25, pp.64~69 (2009)
25. 이병완, "Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors", DIABETIC MEDICINE, 22, pp.1134~1140, BLACKWELL PUBLISHING
26. Kang YH, "The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults", Diabetes Res Clin Pract, 77, pp.306~313 (2007)
27. Lee MY, "Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population", Diabetic Medicine, 25, pp.469~475 (2008), BLACKWELL PUBLISHING
28. Saverymuttu SH, "Ultrasound scanning in the detection of hepatic fibrosis and steatosis", Br Med J, 292, pp.13~15 (1986)
29. Alberti KG, "IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition", Lancet, 366, pp.1059~1062 (2005)
30. Tiikkainen M, "Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content", Diabetes, 52, pp.701~707 (2003)
31. Vozarova B, "High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes", Diabetes, 51, pp.1889~1895 (2002)
32. Schindhelm RK, "Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease", Diabetes Metab Res Rev, 22, pp.437~443 (2006)
33. O’Brien RM, "Regulation of gene expression by insulin", Biochem J, 278, pp.609~619 (1991)
34. Ceriello A, "Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited", Arterioscler Thromb Vasc Biol, 24, pp.816~823 (2004)
35. Targher G, "Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals", Clin Endocrinol (Oxf), 61, pp.700~703 (2004)
36. Yokoyama H, "Inverse association between serum adiponectin level and transaminase activities in Japanese male workers", J Hepatol, 41, pp.19~24 (2004)
37. López-Bermejo A, "Adiponectin, hepatocellular dysfunction and insulin sensitivity", Clin Endocrinol (Oxf), 60, pp.256~263 (2004)
38. Burgert TS, "Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat", J Clin Endocrinol Metab, 91, pp.4287~4294 (2006)

관련 논문AI추천